06.20.25 -- We Must Rethink The Solvents We Use For Peptide Synthesis

Using cGMP grade reagents earlier makes for a seamless transition while maintaining quality and viability.

Explore both traditional cold-wall and convection technology options thoroughly to discern which is most suitable for meeting your cold storage requirements for upcoming projects.

Learn about new materials being considered for single-use cold chain storage containers to reduce or eliminate issues with durability at cold temperatures.

Learn to identify potential product failure points and design robust formulations and processes for lyophilized products backed by solid data.

Magnetic tweezer experiments often seek to measure changes in the extension or relaxation of a polymer, a functionality useful in exploring how different enzymes manipulate polymer structures.

The complex nature of ADCs necessitates meticulous attention to CMC. Gain valuable insights for navigating CMC development, ensuring the delivery of safe and efficacious biopharmaceutical products.

Review the elements of a complex process, prone to misconceptions and pitfalls, to find the “right human tissue” that will yield the desired cell quality and quantity and pass BLA approval.

Discover how a CDMO with extensive experience in protein variant characterization, CQA analytics, and patient-centric product development can ensure the safety and efficacy of your biotherapeutic.

Discover how lyophilization revolutionizes biologic drug manufacturing and ensures potent, stable treatments for complex diseases.

The promise of novel therapeutic modalities can only be realized when effective science is paired with efficient manufacturing to provide cost-effective therapies to patients in need.

Needle innovations, like the use of ultra-thin wall technology for prefilled syringes, support the delivery of drugs with greater volumes and viscosities, which greatly enhances end-user experience.

These real-world case studies highlight best practices and strategies to optimize bioconjugate drug product tech transfers and supplies in the clinical or commercial phase.

Explore the pivotal advancements in ADCs that focus on high-DAR, multispecific designs, and novel payloads, while addressing challenges in manufacturability, scalability, regulatory acceptance, and commercial viability.

AAV therapies require high quality and high titers of viral genomes per dosage, prompting the need for a more efficient AAV manufacturing method to reduce overall costs.

Strategically optimize your upstream and downstream processes and decrease the timeline from optimization to commercial manufacturing.

Learn how pharmaceutical and biotech companies can leverage cutting-edge technology to bring transformative gene therapies to market, making treatments more readily available to patients worldwide.

Designed to enable efficient scalability, a new FBR platform allows operators to use one technology, with a standardized workflow, for their process development, scale-up, and manufacturing processes.